FDA Adverse Event Malfunction Summary report: N

ARCHITECT CMV IGG REAGENT KIT

MDR report key: 19983188 · Received August 14, 2024

Report

Report Number
3008344661-2024-00093
Event Type
Malfunction
Date Received
August 14, 2024
Date of Event
July 25, 2024
Report Date
September 30, 2024
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
LFZ
UDI-DI
0038074021117
PMA / PMN Number
K220949
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION HAS BEEN INCLUDED. NO ADDITIONAL PATIENT DETAILS ARE AVAILABLE.

Additional Manufacturer Narrative · 0

DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. TICKET SEARCH BY LOT INDICATES NORMAL COMPLAINT ACTIVITY. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY ISSUES ASSOCIATED WITH THE CUSTOMER¿S OBSERVATION. A REVIEW OF TICKET TRENDING DID NOT IDENTIFY ANY RELATED TREND REGARDING COMMONALITIES FOR COMPLAINT LOT NUMBER AND ISSUE. CLINICAL SENSITIVITY TESTING MET ACCEPTANCE CRITERIA AND THE PRODUCT IS PERFORMING AS EXPECTED. LABELLING REVIEW CONCLUDES THAT THE ISSUE IS ADEQUATELY ADDRESSED. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ARCHITECT CMV IGG ASSAY WAS IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSE NONREACTIVE ARCHITECT CMV IGG RESULTS FOR ONE PREGNANT PATIENT. THE FOLLOWING DATA WAS PROVIDED: (B)(6) 2024 IGG NEGATIVE; IGM POSITIVE: 2.95 S/CO. (B)(6) 2024 IGG NEGATIVE, IGM POSITIVE: 2.51 S/CO. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSE NONREACTIVE ARCHITECT CMV IGG RESULTS FOR ONE PREGNANT PATIENT. THE FOLLOWING DATA WAS PROVIDED: (B)(6) 2024 IGG NEGATIVE; IGM POSITIVE: 2.95 S/CO. (B)(6) 2024 IGG NEGATIVE, IGM POSITIVE: 2.51 S/CO. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
262164 ARCHITECT CMV IGG REAGENT KIT ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS LFZ ABBOTT IRELAND DIAGNOSTICS DIVISION 61380FZ00 0038074021117

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ARC I2K PROC MOD, 03M74-01, (B)(6) | ARC I2K PROC MOD, 03M74-01, (B)(6)